Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$108,333.00

Nuclear receptors and control of organogenesis

FY 2010-11

Summary
Hormones work by binding to specific molecules in cells known as receptors. Like a lock and key, specific hormones bind to specific receptors. Changes in how these hormones and receptors work have dire consequences for human health. In humans, two receptors named SF-1 and LRH-1 are important for the development of our organs, reproduction, and control of our metabolism. Alteration in how SF-1 and LRH-1 work leads to breast and adrenal cancer, and cardiovascular disease. The lock and key biology that is typical of molecules like SF-1 and LRH-1 is very amenable to manipulation with drugs, therefore making them promising targets for cancer and cardiovascular disease therapies. My work uses a simpler animal, the worm C. elegans, to explore this biology. The worm is only 1 mm long, consisting of 959 cells, and goes from egg to adult in three days. It has elementary organs and has a single protein doing the work of SF-1 and LRH-1. I plan to use one of the simplest organs known to scientists, the worm vulva, to understand how these receptors orchestrate organ formation. Though only comprised of 22 cells, worm vulval development uses many of the same processes and pathways required to form human organs and alteration in many of these processes leads to human cancers. In particular, I am focusing on how small molecules and proteins can be used to subtly change the function of these receptors and how this impacts on organ shape and function. By establishing the worm as a model to study these receptors we can gain fundamental insight into how these proteins work and spur new therapies for breast and adrenal cancer, and cardiovascular disease. Further, the simplicity of the worm makes it a powerful tool to quickly screen new drugs designed to turn SF-1 and LRH-1 on or off.
Program
CIHR Fellowship
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
214638
Name
Ward Jordan D
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Nuclear receptors and control of organogenesis
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$108,333
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Biochemistry; C. Elegans Genetics; Cancer; Cardiovascular Disease; Ligand Identification; Nuclear Hormone Receptors; Organogenesis; Sf-1/Lrh-1; Sumoylation; Transcription/Gene Expression
Abstract
Hormones work by binding to specific molecules in cells known as receptors. Like a lock and key, specific hormones bind to specific receptors. Changes in how these hormones and receptors work have dire consequences for human health. In humans, two receptors named SF-1 and LRH-1 are important for the development of our organs, reproduction, and control of our metabolism. Alteration in how SF-1 and LRH-1 work leads to breast and adrenal cancer, and cardiovascular disease. The lock and key biology that is typical of molecules like SF-1 and LRH-1 is very amenable to manipulation with drugs, therefore making them promising targets for cancer and cardiovascular disease therapies. My work uses a simpler animal, the worm C. elegans, to explore this biology. The worm is only 1 mm long, consisting of 959 cells, and goes from egg to adult in three days. It has elementary organs and has a single protein doing the work of SF-1 and LRH-1. I plan to use one of the simplest organs known to scientists, the worm vulva, to understand how these receptors orchestrate organ formation. Though only comprised of 22 cells, worm vulval development uses many of the same processes and pathways required to form human organs and alteration in many of these processes leads to human cancers. In particular, I am focusing on how small molecules and proteins can be used to subtly change the function of these receptors and how this impacts on organ shape and function. By establishing the worm as a model to study these receptors we can gain fundamental insight into how these proteins work and spur new therapies for breast and adrenal cancer, and cardiovascular disease. Further, the simplicity of the worm makes it a powerful tool to quickly screen new drugs designed to turn SF-1 and LRH-1 on or off.
Competitiondate
201010
Approvedterm2
2 yrs 2 mths
Pinamesdelim
Ward, Jordan D
Approvedterm
2 ans 2 mois
Cihrcontribution2
~ $108,333~ $0~
Direct Payment - $108,333 Grant (2010-11) | Canada Spends